| 英文名稱 |
中文名稱 |
CAS號(hào) |
操作 |
|
2-氯-4-氟煙酸甲酯 |
1805523-13-0 |
詳細(xì)
|
| EN1441 |
|
2196448-47-0 |
詳細(xì)
|
| NC318 |
|
|
詳細(xì)
|
| tafasitamab |
|
1422527-84-1 |
詳細(xì)
|
| tiragolumab |
|
1918185-84-8 |
詳細(xì)
|
| rozanolixizumab |
|
1584645-37-3 |
詳細(xì)
|
| GSK4418959/IDE275 |
|
3064599-36-3 |
詳細(xì)
|
| ABT-102 |
|
808756-71-0 |
詳細(xì)
|
| Tamoxifen Impurity G |
|
68047-07-4 |
詳細(xì)
|
| RO7567132 |
|
|
詳細(xì)
|
| 1400W 2HCl |
N-[3-(氨甲基)芐基]乙脒二鹽酸鹽 |
214358-33-5 |
詳細(xì)
|
| BAY-985 |
|
2409479-29-2 |
詳細(xì)
|
| RBN-2397 |
|
2381037-82-5 |
詳細(xì)
|
| 4-Hydroxy-3-methoxyphenylglycol sulfate potassium salt |
4-羥基-3-甲氧基苯基乙二醇-4-硫酸鉀鹽 |
71324-20-4 |
詳細(xì)
|
| 1H-Benzotriazole-7-carboxylic acid, 1-methyl-5-(2-methyl[1,1-biphenyl]-4-yl)- |
AG-636 |
1623416-31-8 |
詳細(xì)
|
| Pyrazolo[1,5-a]pyrimidin-7(4H)-one, 3-(1-cyclohexen-1-yl)-6-(4-methoxyphenyl)-2-phenyl-5-(2-pyridinylamino)- |
|
2201056-66-6 |
詳細(xì)
|
| NCT-58 |
化合物NCT-58 |
2411429-33-7 |
詳細(xì)
|
| Britanin |
旋覆花內(nèi)酯 |
33627-28-0 |
詳細(xì)
|
| 9-Ethyl-9H-carbazole-3,6-dicarboxaldehyde |
N-乙基咔唑-3,6-二甲醛 |
70207-46-4 |
詳細(xì)
|
| URMC-099 |
|
1229582-33-5 |
詳細(xì)
|
| GSK484 |
CS-2265 |
1652591-81-5 |
詳細(xì)
|
| GSK864 |
1816331-66-4 |
1816331-66-4 |
詳細(xì)
|
| THAL-SNS-032 |
|
2139287-33-3 |
詳細(xì)
|
| oxyphenisatinedi(acetate) |
雙醋酚丁 |
115-33-3 |
詳細(xì)
|
| SB265610 |
化合物SB-265610 |
211096-49-0 |
詳細(xì)
|
| MK-2206 2HCl |
|
1032350-13-2 |
詳細(xì)
|
| BNC-105 |
BNC105 |
945771-74-4 |
詳細(xì)
|
| 2-[6-(4-Chloro-phenyl)-1-Methyl-4H-3-oxa-2,5-diaza-benzo[e]azulen-4-yl]-acetaMide |
BET抑制劑 |
1380087-89-7 |
詳細(xì)
|
| Gentamicin |
慶大霉素 |
1403-66-3 |
詳細(xì)
|
| Gigantol |
石斛酚 |
83088-28-2 |
詳細(xì)
|
| VH298 |
|
2097381-85-4 |
詳細(xì)
|
| opiranserin hydrochloride |
|
1440796-75-7 |
詳細(xì)
|
| ACBI1 |
|
2375564-55-7 |
詳細(xì)
|
| NVP-DKY709 |
|
2291360-73-9 |
詳細(xì)
|
| AZD0022 |
|
2958627-18-2 |
詳細(xì)
|
| Nelfinavir |
甲磺酸萘非那韋 |
159989-64-7 |
詳細(xì)
|
| 89738362-9 |
AST-1306 |
897383-62-9 |
詳細(xì)
|
| SLx-2119 |
2-[3-[4-[(1H-吲唑-5-基)氨基]喹唑啉-2-基]苯氧基]-N-異丙基乙酰胺 |
911417-87-3 |
詳細(xì)
|
| 4SC-202 |
4SC-202(鹽的形式) |
1186222-89-8 |
詳細(xì)
|
| GI 254023X |
(ALPHAR)-N-[(1S)-2,2-二甲基-1-[(甲基氨基)羰基]丙基]-ALPHA-[(1S)-1-(甲?；u基氨基)乙基]苯戊酰胺 |
260264-93-5 |
詳細(xì)
|
| TIC-10 Analogue |
TIC-10 |
41276-02-2 |
詳細(xì)
|
| SBI0206965 |
SBI0206965; SBI-0206965; SBI 0206965. |
1884220-36-3 |
詳細(xì)
|
| ON1231320 |
CS-2589 |
1312471-39-8 |
詳細(xì)
|
| NCT-503 |
NCT503 |
1916571-90-8 |
詳細(xì)
|
| Emixustat Hydrochloride |
特戈拉贊 |
942195-55-3 |
詳細(xì)
|
| Dapansutrile |
3-甲磺?；?/td>
| 54863-37-5 |
詳細(xì)
|
| varlilumab |
|
1393344-72-3 |
詳細(xì)
|
| Sage217 |
CS-2797 |
1632051-40-1 |
詳細(xì)
|
| Lazertinib |
YH-25448 |
1903008-80-9 |
詳細(xì)
|
| AZD-7648 |
|
2230820-11-6 |
詳細(xì)
|
| ASP-2905) |
化合物ASP-2905 |
792184-90-8 |
詳細(xì)
|
| PEAQX |
化合物PEAQX |
459836-30-7 |
詳細(xì)
|
| 4-Oxazolecarboxamide, N-[5-[(3R)-3-hydroxy-1-pyrrolidinyl]-2-(4-morpholinyl)oxazolo[4,5-b]pyridin-6-yl]-2-(2-methyl-4-pyridinyl)- |
|
1801344-14-8 |
詳細(xì)
|
| DPTIP |
|
351353-48-5 |
詳細(xì)
|
| Anagrelide Hydrochloride |
鹽酸阿那格雷 |
58579-51-4 |
詳細(xì)
|
| UCB-9260 |
|
1515888-53-5 |
詳細(xì)
|
| 4-(2,3-Dihydro-1,4-benzodioxin-6-yl)-2,4-dihydro-5-[(5-nitro-2-thiazolyl)thio]-3H-1,2,4-triazol-3-one |
|
883065-90-5 |
詳細(xì)
|
| W146 hydrate |
W146HYDRATE |
909725-61-7 |
詳細(xì)
|
| AZD-4818 |
CCR1 antagonist |
1003566-93-5 |
詳細(xì)
|
| 3-broMopyrido |
3-溴吡啶并[2,3-D]噠嗪-8(7H)-酮 |
909186-02-3 |
詳細(xì)
|
| TAS-115 |
1190836-34-0 |
1190836-34-0 |
詳細(xì)
|
| Propionyl-L-carnitine solution |
丙酰左旋肉堿鹽酸鹽 |
20064-19-1 |
詳細(xì)
|
| 9-ING-41 |
|
1034895-42-5 |
詳細(xì)
|
| PF06700841 |
CS-2861 |
1883299-62-4 |
詳細(xì)
|
| AZD-5672 |
|
780750-65-4 |
詳細(xì)
|
| Bepridil hydrochloride |
鹽酸芐普地爾 |
74764-40-2 |
詳細(xì)
|
| Colchicoside |
秋水仙堿EP雜質(zhì)D |
477-29-2 |
詳細(xì)
|
| BI-749327 |
|
2361241-23-6 |
詳細(xì)
|
| TPX-0022 |
CSF1R-IN-2 |
2271119-26-5 |
詳細(xì)
|
| α-Amyrin |
alpha-香樹精 |
638-95-9 |
詳細(xì)
|
| ULK-101 |
2-Thiophenecarboxamide, N-[(1S)-1-cyclopropyl-2,2,2-trifluoroethyl]-4-[6-(4-fluorophenyl)pyrazolo[1,5-a]pyrimidin-3-yl]- |
2443816-45-1 |
詳細(xì)
|
| GPR183 |
化合物GPR183 |
1241280-25-0 |
詳細(xì)
|
| SR144528 |
化合物 SR144528 |
192703-06-3 |
詳細(xì)
|
| PROTAC BRD4 Degrader-13 |
|
2417370-71-7 |
詳細(xì)
|
| Br-Val-Ala-NH2-bicyclo[1.1.1]pentane-7-MAD-MDCPT |
|
2857037-70-6 |
詳細(xì)
|
| Propanamide, N,N-dimethyl-2-[[4-(2-methylphenyl)-2-oxo-2H-1-benzopyran-7-yl]oxy]- |
化合物L(fēng)DC195943(IMT1) |
2304621-31-4 |
詳細(xì)
|
| [2,3-Bipyridine]-5-carboxamide, N-[4-[2-amino-5-[4-[(2R)-1,4-dioxan-2-ylmethoxy]-3-methoxyphenyl]-3-pyridinyl]-3-fluorophenyl]-1,4-dihydro-5-methyl-4-oxo-1-[(tetrahydro-2H-pyran-4-yl)methyl]- |
化合物DS-1205 |
1855860-24-0 |
詳細(xì)
|
| codrituzumab |
|
1365267-33-9 |
詳細(xì)
|
| AB680 |
AB-680 |
2105904-82-1 |
詳細(xì)
|
| NSC 146109 |
NSC 146109 (HYDROCHLORIDE);XI-011 |
59474-01-0 |
詳細(xì)
|
| Batatasin IV |
山藥素IV |
60347-67-3 |
詳細(xì)
|
| Werner syndrome RecQ helicase-IN-1 |
[1,2,4]TRIAZOLO[1,5-A]PYRIMIDINE-4(7H)-ACETAMIDE, N-[2-CHLORO-4-(TRIFLUOROMETHYL)PHENYL]-2-(3,6-DIHYDRO-2H-PYRAN-4-YL)-5-ETHYL-6-[4-[(5-HYDROXY-6-METHYL-4-PYRIM |
2869954-34-5 |
詳細(xì)
|
| vorsetuzumab |
|
1165740-62-4 |
詳細(xì)
|
| M0324 |
|
|
詳細(xì)
|
| EG-011 |
|
2377113-41-0 |
詳細(xì)
|
| tetrabutylazanium,nitrite |
四丁基亞硝酸銨 |
26501-54-2 |
詳細(xì)
|
| HS-276 |
化合物 HS-276 |
2767422-72-8 |
詳細(xì)
|
| L755507 |
L755,507 |
159182-43-1 |
詳細(xì)
|
| EDO-S101 |
|
1236199-60-2 |
詳細(xì)
|
| SRI-37330 HCl |
SRI-37330 HYDROCHLORIDE; SRI37330 HYDROCHLORIDE; SRI 37330 HYDROCHLORIDE; SRI-37330 HCL; SRI37330 HCL; SRI 37330 HCL; |
2322245-49-6 |
詳細(xì)
|
| Nω-Hydroxy-nor-L-Arginine Dihydrochloride |
NΩ-羥基或- L -精氨酸鹽酸鹽 |
291758-32-2 |
詳細(xì)
|
| HG106 |
ACETAMIDE, 2-CHLORO-N-[2-(4-METHOXYPHENYL)-2H-BENZOTRIAZOL-5-YL]- |
928712-10-1 |
詳細(xì)
|
| SHP2-IN-6 |
JAB-3068 |
2169223-48-5 |
詳細(xì)
|
| 1H-Pyrazole-3-carboxamide, 5-ethyl-4-methyl-N-[4-(2S)-2-morpholinylphenyl]- |
化合物RALMITARONT |
2133417-13-5 |
詳細(xì)
|
| LSZ-102 |
CS-2791 |
2135600-76-7 |
詳細(xì)
|
| (Rac)-AF710B |
|
1235733-73-9 |
詳細(xì)
|
| GDC-2992 |
|
2753651-10-2 |
詳細(xì)
|
| 6K465 |
|
2702965-27-1 |
詳細(xì)
|
| Quiflapon |
喹夫拉朋 |
136668-42-3 |
詳細(xì)
|
| FAP targeting peptide for FXX489 |
|
3076328-74-7 |
詳細(xì)
|